Global Sexually Transmitted Disease (STD) Testing Market 2014-2018

性感染症(STD)検査製品の世界市場:クラミジア、淋菌、梅毒、エイズ/HIV、HSV、HPV、軟性下疳

◆タイトル:Global Sexually Transmitted Disease (STD) Testing Market 2014-2018
◆商品コード:IRTNTR4524
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2014年10月22日
◆ページ数:85
◆資料形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥270,000見積依頼/購入/質問フォーム
Five UserUSD2,800 ⇒換算¥302,400見積依頼/購入/質問フォーム
Enterprise License(社内共有可)USD3,500 ⇒換算¥378,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

本調査レポートでは、"性感染症(STD)検査製品の世界市場:クラミジア、淋菌、梅毒、エイズ/HIV、HSV、HPV、軟性下疳"について調査・分析し、エグゼクティブサマリー、市場概観、市場規模及び予測、用途別分析、需要先別分析、主要地域別分析、市場シェア、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析等の情報をお届けいたします。

Sexually transmitted diseases (STDs) can be caused by infections that are passed from one person to another person through sexual contact. It can also be transmitted through nonsexual modes such as from mother to infant during pregnancy, childbirth, blood transfusions, and through shared needles. People are sexually active at a younger age and involve in multiple partners relationship because of which STDs have become more common in recent years. In addition, people can pass STDs to their sexual partners without any symptoms to themselves.

TechNavio’s analysts forecast the Global Sexually Transmitted Disease Testing market to grow at a CAGR of 5.64 percent over the period 2013-2018.

[Covered in this Report]
The Global Sexually Transmitted Disease Testing market can be segmented based on the revenue generated from various applications such as chlamydia testing, gonorrhea testing, syphilis testing, HIV testing, HSV testing, HPV testing, and chancroid testing.
TechNavio’s report, Global Sexually Transmitted Disease Testing Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the APAC and EMEA regions; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key Regions]
• Americas
• APAC
• EMEA

[Key Vendors]
• Alere
• Becton Dickinson and Company
• bioMérieux
• F. Hoffmann-La Roche

[Other Prominent Vendors]
• Abbott
• Bio-Rad
• Cepheid
• DiaSorin
• Erba Diagnostics
• Grifols
• Hologic Gen-Probe
• Hospitex Diagnostics
• Siemens Healthcare
• Qiagen

[Market Driver]
• Growing Incidence of STDs in Adolescents and Young Adults
• For a full, detailed list, view our report

[Market Challenge]
• Accurate Diagnostics Testing
• For a full, detailed list, view our report

[Market Trend]
• Ready-to-use Reagents
• For a full, detailed list, view our report

[Key Questions Answered in this Report]
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

【資料の目次】

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Market Landscape
05.1 Market Overview
05.2 Market Size and Forecast
06. Introduction
06.1 Five Forces Analysis
07. Market Segmentation by Application
07.1 Global Chlamydia Testing Market
07.1.1 Market Size and Forecast
07.2 Global Gonorrhea Testing Market
07.2.1 Market Size and Forecast
07.3 Global Syphilis Testing Market
07.3.1 Market Size and Forecast
07.4 Global HIV Testing Market
07.4.1 Market Size and Forecast
07.5 Global HSV Testing Market
07.5.1 Market Size and Forecast
07.6 Global HPV Testing Market
07.6.1 Market Size and Forecast
07.7 Global Chancroid Testing Market
07.7.1 Market Size and Forecast
08. Market Segmentation by End-users
08.1 Global STD Laboratory Testing Market
08.1.1 Market Size and Forecast
08.2 Global STD Point-of-Care Testing Market
08.2.1 Market Size and Forecast
09. Geographical Segmentation
09.1 STD Testing Market in the Americas
09.1.1 Market Size and Forecast
09.2 STD Testing Market in the EMEA Region
09.2.1 Market Size and Forecast
09.3 STD Testing Market in the APAC Region
09.3.1 Market Size and Forecast
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and their Impact
17. Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.1.2 Mergers and Acquisitions
17.2 Market Share Analysis 2013
17.3 Other Prominent Vendors
18. Key Vendor Analysis
18.1 Alere
18.1.1 Key Facts
18.1.2 Business Overview
18.1.3 Business Segmentation by Revenue 2013
18.1.4 Business Segmentation by Revenue 2012 and 2013
18.1.5 Geographical Segmentation by Revenue 2013
18.1.6 Business Strategy
18.1.7 Recent Developments
18.1.8 SWOT Analysis
18.2 Becton, Dickinson and Co.
18.2.1 Key Facts
18.2.2 Business Description
18.2.3 Business Segmentation
18.2.4 Revenue Segmentation by Business
18.2.5 Segmental Revenue Comparison – 2013 and 2012
18.2.6 Revenue Segmentation by Geography
18.2.7 Business Strategy
18.2.8 Key Developments
18.2.9 SWOT Analysis
18.2.10 SWOT Overview
18.3 bioMeriux
18.3.1 Key Facts
18.3.2 Business Overview
18.3.3 Business Segmentation by Revenue 2013
18.3.4 Geographical Segmentation by Revenue 2013
18.3.5 Business Strategy
18.3.6 Recent Developments
18.3.7 SWOT Analysis
18.4 Roche Diagnostics
18.4.1 Key Facts
18.4.2 Business Overview
18.4.3 Business Segmentation by Revenue 2013
18.4.4 Geographical Segmentation by Revenue 2013
18.4.5 Business Strategy
18.4.6 Recent Developments
18.4.7 SWOT Analysis
19. Other Reports in this Series

[List of Exhibits]
Exhibit 1: Segmentation of Global STD Testing Market
Exhibit 2: Market Research Methodology
Exhibit 3: Global STD Testing Market 2013-2018 (US$ billion)
Exhibit 4: Global STD Testing Market Segmentation by Application
Exhibit 5: The Application and Limitations of Diagnostic Tests in Different Stages of Syphilis
Exhibit 6: Socioeconomic Factors Affecting HIV Risks
Exhibit 7: Types of HPV testing
Exhibit 8: Clinical Manifestations Associated with HPV
Exhibit 9: Diagnostics Tests for Chancroid
Exhibit 10: Global STD Testing Market Segmentation by Application 2013
Exhibit 11: Global Chlamydia Testing Market 2013-2018 (US$ billion)
Exhibit 12: Global Gonorrhea Testing Market 2013-2018 (US$ billion)
Exhibit 13: Global Syphilis Testing Market 2013-2018 (US$ billion)
Exhibit 14: Estimated Number of Adverse Outcomes Associated With Syphilis In Pregnancy in Worst, Middle, and Best Case Scenarios of Testing and Treatment Coverage In 2008
Exhibit 15: Global HIV Testing Market 2013-2018 (US$ billion)
Exhibit 16: amfAR Regional Estimation of HIV/AIDS
Exhibit 17: Global HSV Testing Market 2013-2018 (US$ billion)
Exhibit 18: Global HPV Testing Market 2013-2018 (US$ billion)
Exhibit 19: Global Chancroid Testing Market 2013-2018 (US$ billion)
Exhibit 20: Global STD Testing Market Segmentation by Application 2013-2018
Exhibit 21: Global STD Testing Market Segmentation by Application 2013-2018 (US$ billion)
Exhibit 22: Global STD Testing Market Segmentation by End-user
Exhibit 23: Global STD Testing Market Segmentation by End-user 2013
Exhibit 24: Global STD Laboratory Testing Market 2013-2018 (US$ billion)
Exhibit 25: Global STD Point-of-Care Testing Market 2013-2018 (US$ billion)
Exhibit 26: Global STD Testing Market Segmentation by End-users 2013-2018
Exhibit 27: Global STD Testing Market Segmentation by End-users 2013-2018 (US$ billion)
Exhibit 28: Global STD Testing Market by Geographical Segmentation 2013
Exhibit 29: STD Testing Market in the Americas 2013-2018 (US$ billion)
Exhibit 30: STD Testing Market in the EMEA Region 2013-2018 (US$ billion)
Exhibit 31: STD Testing Market in the APAC Region 2013-2018 (US$ billion)
Exhibit 32: Global STD Testing Market by Geographical Segmentation 2013-2018
Exhibit 33: Global STD Testing Market by Geographical Segmentation 2013-2018 (US$ billion)
Exhibit 34: Chlamydia and Gonorrhea rates (per 100,000) Ages 15-19, By Gender, 2011
Exhibit 35: Alere: Business Segmentation by Revenue 2013
Exhibit 36: Alere: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 37: Alere: Geographical Segmentation by Revenue 2013
Exhibit 38: Product Categorization of Becton, Dickinson and Co.
Exhibit 39: Revenue Segmentation of Becton, Dickinson and Co. 2013
Exhibit 40: Revenue Comparison (US$ million)
Exhibit 41: Revenue Segmentation of Becton, Dickinson and Co. by Geography 2013
Exhibit 42: bioMeriux: Business Segmentation by Revenue 2013
Exhibit 43: bioMeriux: Geographical Segmentation by Revenue 2013
Exhibit 44: Roche Diagnostics: Business Segmentation by Revenue 2013
Exhibit 45: Roche Diagnostics: Geographical Segmentation by Revenue 2013



【掲載企業】

Alere ,Becton Dickinson and Company,bioMérieux ,F. Hoffmann-La Roche ,Abbott ,Bio-Rad,Cepheid,DiaSorin ,Erba Diagnostics,Grifols,Hologic Gen-Probe,Hospitex Diagnostics,Siemens Healthcare,Qiagen

【資料のキーワード】

性感染症(STD)検査、クラミジア検査、淋菌検査、梅毒検査、エイズ/HIV検査、HSV検査、HPV検査、軟性下疳検査、診断、医療機器

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[性感染症(STD)検査製品の世界市場:クラミジア、淋菌、梅毒、エイズ/HIV、HSV、HPV、軟性下疳]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆